ライフサイエンスコーパス: Nurses' Health Study

1 from Europe (ESTHER) and the United States (Nurses' Health Study).

2 m healthy 50-60-year-old participants in the Nurses' Health Study.

3 1,941 women aged >=60 y participating in the Nurses' Health Study.

4 Health Professionals Follow-Up Study and the Nurses' Health Study.

5 years of follow-up from 1989 to 2004 in the Nurses' Health Study.

6 ls not using postmenopausal hormones) in the Nurses' Health Study.

7 -up among 107 130 members of the prospective Nurses' Health Study.

8 Study, the Multiethnic Cohort Study, and the Nurses' Health Study.

9 ident lung cancers among 78,612 women in the Nurses' Health Study.

10 cognitive function among older women in the Nurses' Health Study.

11 ticipated in two case-control studies in the Nurses' Health Study.

12 nals Follow-Up Study and 53,772 women in the Nurses' Health Study.

13 TL among 7,813 women aged 43-70 years in the Nurses' Health Study.

14 72,719 women (age, 40-73 y) enrolled in the Nurses' Health Study.

15 of cardiovascular disease or cancer from the Nurses' Health Study.

16 opausal breast cancer in 86,621 women in the Nurses' Health Study.

17 24 y of follow-up in women with CVD from the Nurses' Health Study.

18 history of hypertension or diabetes from the Nurses' Health Study.

19 bjects (n = 549 each) were selected from the Nurses' Health Study.

20 c mortality among 50,112 participants in the Nurses' Health Study.

21 ess and depression risk prospectively in the Nurses' Health Study.

22 risk of FI among postmenopausal women in the Nurses' Health Study.

23 the Health Professionals Follow-up Study and Nurses' Health Study.

24 pigmentation among 49,323 white women in the Nurses' Health Study.

25 studies, including among 1,982 women in the Nurses' Health Study.

26 orted hearing loss among 55,850 women in the Nurses' Health Study.

27 with benign breast disease according to the Nurses' Health Studies.

28 st longitudinal cohort studies of women, the Nurses' Health studies.

29 most robust women's longitudinal cohorts-the Nurses' Health Studies.

30 2010-2012), conducted among subgroups of the Nurses' Health Studies.

31 h amyotrophic lateral sclerosis (ALS) in the Nurses' Health Study (1976-2004), the Health Professiona

32 By using 2 case-control GWAS (the Nurses' Health Study, 1976-2006, and the Health Professi

33 The authors included 76,364 women from the Nurses' Health Study (1980 to 2012), 92,946 women from t

34 uals in 2 US nationwide prospective cohorts (Nurses' Health Study (1980-2008) and Health Professional

35 50,151 women and men aged >/=20 years in the Nurses' Health Study (1980-2008), the Nurses' Health Stu

36 specific mortality among 76,464 women in the Nurses' Health Study (1980-2010) and 42,498 men in the H

37 Two large US prospective cohort studies, the Nurses' Health Study (1980-2010) and Health Professional

38 ne/threonine kinase (BRAF), mutation) in the Nurses' Health Study (1980-2010) and the Health Professi

39 We followed 80,978 women from the Nurses' Health Study (1980-2012) and 39,434 men from the

40 We followed 84,628 women (Nurses' Health Study, 1980 to 2010), and 42,908 men (Hea

41 s at baseline or diagnosed during follow-up (Nurses' Health Study: 1980-2014, Health Professionals Fo

42 We used data on 87,166 women in the Nurses' Health Study (1982-2010) and 32,959 men in the H

43 A total of 63,810 women in the Nurses' Health Study (1984 to 2010) and 41,622 men in th

44 prospectively followed 71,141 women from the Nurses' Health Study (1984-2008) and 42,135 men from the

45 prospectively followed 74,248 women from the Nurses' Health Study (1984-2008), 90,411 women from the

46 in and incident T2D in 72,992 women from the Nurses' Health Study (1984-2008), 92,088 women from Nurs

47 ing a questionnaire in 70,842 women from the Nurses' Health Study (1984-2010) and 40,789 men from the

48 207,556 women and men [73,228 women from the Nurses' Health Study (1984-2010), 92,158 women from the

49 We collected data from the Nurses' Health Study (1984-2012) and Health Professional

50 We included 69,949 women from the Nurses' Health Study (1984-2012), 90,239 women from the

51 ata from 166,903 women and 41,931 men in the Nurses' Health Study (1984-2014), Nurses' Health Study I

52 of whom 1,897 developed incident T2D, in the Nurses' Health Study (1984-2016), Nurses' Health Study I

53 We included 73,710 women in NHS (Nurses' Health Study) (1984 to 2012), 92,329 women in NH

54 participants from a U.S. female cohort, the Nurses' Health Study (1986-2006), and a U.S. male cohort

55 dy (1988-2008), 72,231 women enrolled in the Nurses' Health Study (1986-2008), and 90,836 women enrol

56 We followed 67,139 women from the Nurses' Health Study (1986-2012) and 43,541 men from the

57 ow-Up Study (1986-2012), 76,531 women in the Nurses' Health Study (1986-2012), and 81,597 women in th

58 860 women (7,582 breast cancer cases) in the Nurses' Health Study (1988-2004) and Nurses' Health Stud

59 data from 2 prospective cohort studies, the Nurses' Health Study (1988-2012; n = 78,516) and Nurses'

60 ries/uterus from the Nurses' Health studies (Nurses' Health Study (1989-1990) and Nurses' Health Stud

61 ding 1,528 cases and 2,844 controls from the Nurses' Health Study (1989-2004) and Nurses' Health Stud

62 tudy (1994 to 2008) and 144 women within the Nurses' Health Study (1990 to 2010) with incident confir

63 Using data from 52,110 women in the Nurses' Health Study (1990), we reproduced the cross-sec

64 omen aged 32-70 years at blood draw from the Nurses' Health Study (1990-2006) and Nurses' Health Stud

65 We followed 63 412 women from the NHS (Nurses' Health Study; 1990-2012) and 29 966 men from the

66 rticipants from a cohort of older women (the Nurses' Health Study, 1996-2008), a cohort of younger wo

67 in the Nurses' Health Study (1980-2008), the Nurses' Health Study 2 (1989-2009), and the Health Profe

68 lth Study (1984-2012), 90,239 women from the Nurses' Health Study 2 (1991-2011), and 40,539 men from

69 atitis (AD) and cardiovascular events in the Nurses' Health Study 2, a cohort of US women.

70 se with CVD events among 66 798 women in the Nurses' Health Study 2.

71 itis (AD) in a large cohort of US women, the Nurses' Health Study 2.

72 haracterized cohort studies of US women: the Nurses' Health Study (2000-2010) and Nurses' Health Stud

73 ly in a nested case-control study within the Nurses' Health Study [218 melanoma, 285 squamous cell ca

74 tudies of diabetic patients: the prospective Nurses' Health Study (309 CHD cases, and 544 control sub

75 biennially in the prospective cohorts of the Nurses' Health Study (63 893 women; 1984-2012) and the H

76 participants with incident diabetes from the Nurses' Health Study (8970 participants) and Health Prof

77 ciations with IGF-axis protein levels in the Nurses' Health Study, a cohort of middle-aged women.

78 For participants in the Nurses' Health Study, a nationwide prospective cohort of

79 (EPA)'s Air Toxics tract-level data with the Nurses' Health Study, a prospective cohort of female nur

80 Using data from the Nurses' Health Study, a prospective cohort study of 51,3

81 lected in 1989-1990 from participants of the Nurses' Health Study, a study of nurses from 11 US state

82 In the Nurses' Health Study, a US prospective cohort study span

83 ore than 20 years of follow-up data from the Nurses' Health Study (all female registered nurses) and

84 We used data from the Nurses' Health Study, an ongoing nationwide prospective

85 Participants (49 033 women in the Nurses Health Study and 20 066 men in the Health Profess

86 We followed 75 889 women from the Nurses' Health Study and 38 961 men from the Health Prof

87 and eight hundred eighty-nine women from the Nurses' Health Study and 38,961 men from Health Professi

88 A total of 82,348 women in the Nurses' Health Study and 40,278 men in the Health Profes

89 n clinical follow-up of 109,046 women in the Nurses' Health Study and 47,684 men in the Health Profes

90 23 female nurses for 24 y (1986-2010) in the Nurses' Health Study and estimate the relative risk of b

91 wed up, from 1984 until May 31, 2010, in the Nurses' Health Study and from 1986 until January 31, 201

92 7 nondiabetic CHD-negative controls from the Nurses' Health Study and Health Professionals Follow-up

93 (VTE) among 129,430 US women and men in the Nurses' Health Study and Health Professionals Follow-up

94 We conducted a nested case-control study in Nurses' Health Study and Health Professionals Follow-Up

95 In an analysis data from the Nurses' Health Study and Health Professionals Follow-up

96 n 96,000 white postmenopausal women from the Nurses' Health Study and men aged 50 years and older fro

97 tosus among 184,643 US women followed in the Nurses' Health Study and Nurses' Health Study II cohorts

98 spective cohort study, with cohorts from the Nurses' Health Study and the Health Professionals Follow

99 through June 2012) among participants in the Nurses' Health Study and the Health Professionals Follow

100 l participants of European ancestry from the Nurses' Health Study and the Health Professionals Follow

101 than is an intake in the recent past in the Nurses' Health Study and the Health Professionals Follow

102 rom 2 large, prospective cohort studies, the Nurses' Health Study and the Health Professionals Follow

103 atients with rectal or colon cancer from the Nurses' Health Study and the Health Professionals Follow

104 Using data from the Nurses' Health Study and the Health Professionals Follow

105 and 4564 men from 2 prospective cohorts: The Nurses' Health Study and the Health Professionals Follow

106 PATIENTS: Two US prospective cohort studies (Nurses' Health Study and the Health Professionals Follow

107 In the Nurses' Health Study and the Health Professionals Follow

108 In an analysis of data from the Nurses' Health Study and the Health Professionals Follow

109 2272 in RBP4 in independent samples from the Nurses' Health Study and the Invecchiare in Chianti Stud

110 measured in blood collected in 1989 to 1990 (Nurses' Health Study) and 1993 to 1994 (Health Professio

111 ovided prediagnosis blood specimens in 1990 (Nurses' Health Study) and 1994 (Health Professionals' Fo

112 Blood samples were collected in 1989-1990 (Nurses' Health Study) and 2000-2002 (ESTHER).

113 sionals) from June 1, 1980, to May 31, 2010 (Nurses' Health Study) and January 1, 1986, to December 3

114 ion Study that was conducted within the NHS (Nurses' Health Study) and NHS II longitudinal cohorts.

115 al women with intact ovaries/uterus from the Nurses' Health Studies, and estimated lifetime ovulatory

116 2014 in 75,180 postmenopausal women from the Nurses' Health Study, and between 1986 and 2014 in 38,39

117 dy among women of European ancestry from the Nurses' Health Study, and identified genome-wide signifi

118 cases matched 1:1 to controls (from the NHS [Nurses' Health Study]) and in a replication cohort of 2,

119 ge range: 50-77 y) without depression in the Nurses' Health Study at baseline (1996) who were followe

120 aged 30 to 55 years who participated in the Nurses' Health Study, attendance at religious services o

121 In the Nurses' Health Study, bowel movement frequency was self-

122 s conducted in postmenopausal women from the Nurses' Health Study cohort (n = 73,572).

123 Professionals Follow up Study (HPFS) and the Nurses' Health Study cohort (NHS) additive and multiplic

124 w-up was completed on June 30, 2012, for the Nurses' Health Study cohort and January 31, 2010, for th

125 eveloped CHD and 472 matched controls in the Nurses' Health Study cohort during 16 years of follow-up

126 In independent validation data (Nurses' Health Study cohort) the breast and ovarian canc

127 sted in the Physicians' Health Study and the Nurses' Health Study cohorts to determine whether patter

128 These methods are applied to Nurses' Health Study data from 1980-2006, during which 3

129 vironment-Wide Association Study approach to Nurses' Health Study data to explore comprehensively and

130 were pooled from 4 large, US-based cohorts: Nurses' Health Study (enrollment 1976; follow-up 1982-20

131 ional study of 105,986 women enrolled in the Nurses' Health Study followed up from 1980 until 2008 wi

132 ed up over 26 years, who participated in the Nurses' Health Study, followed up for 3,317,425 person-y

133 incident diabetes case-control pairs in the Nurses' Health Study, for whom levels of plasma fetuin-A

134 and three hundred and sixty-two women in the Nurses' Health Study, free of CHD and stroke at baseline

135 in postmenopausal women (n = 121,700) in the Nurses' Health Study from 1980-2010.

136 e participants of the U.S.-based prospective Nurses' Health Study from 1988 to 2008.

137 ctive cohort study of 81,722 US women in the Nurses' Health Study from June 1984 to June 2010.

138 ionals Follow-up Study (n = 42,902 men), the Nurses' Health Study I (n = 59,994 women), and the Nurse

139 d 40-75 years; follow-up from 1986 to 2010), Nurses' Health Study I (NHS I) (90,235 women aged 30-55

140 Nurses' Health Study I and II and Health Professionals F

141 3,587 nondiabetic women in 2 US cohorts, the Nurses' Health Study I in 2000 and the Nurses' Health St

142 m the Nurses' Mothers' Cohort (2001) and the Nurses' Health Study II (1989 and 1991), the following i

143 in the Nurses' Health Study (1988-2004) and Nurses' Health Study II (1989-2005) who recalled their b

144 nd subsequent CHD among 116 430 women in the Nurses' Health Study II (1989-2009).

145 es' Health Study (1988-2012; n = 78,516) and Nurses' Health Study II (1989-2013; n = 114,559), we exa

146 2D, in the Nurses' Health Study (1984-2016), Nurses' Health Study II (1989-2016), and Health Professi

147 Study (1980 to 2012), 92,946 women from the Nurses' Health Study II (1991 to 2013), and 41,526 men f

148 -control study nested within the prospective Nurses' Health Study II (1991-2001).

149 We included 95,809 women from Nurses' Health Study II (1991-2005).

150 Health Study (1984-2008), 92,088 women from Nurses' Health Study II (1991-2009) and 40,722 men from

151 lth Study (1984-2008), 90,411 women from the Nurses' Health Study II (1991-2009), and 40,498 men from

152 lth Study (1984-2010), 92,158 women from the Nurses' Health Study II (1991-2011), and 42,170 men from

153 h Study (1986-2012), and 81,597 women in the Nurses' Health Study II (1991-2013).

154 men in the Nurses' Health Study (1984-2014), Nurses' Health Study II (1991-2015), and Health Professi

155 dy (1986-2008), and 90,836 women enrolled in Nurses' Health Study II (1993-2007).

156 tudies (Nurses' Health Study (1989-1990) and Nurses' Health Study II (1996-1999)) in an analysis of t

157 rom the Nurses' Health Study (1989-2004) and Nurses' Health Study II (1996-2003).

158 rom the Nurses' Health Study (1990-2006) and Nurses' Health Study II (1997-2005).

159 en: the Nurses' Health Study (2000-2010) and Nurses' Health Study II (1997-2007).

160 ong 3,135 women (mean age = 59 years) in the Nurses' Health Study II (2012-2018).

161 Using data on women aged 53-70 years from Nurses' Health Study II (2017-2018; n = 49,045), we asse

162 d ASD in the children of participants in the Nurses' Health Study II (325 cases, 22,101 controls).

163 We included the subsample of the Nurses' Health Study II (54 224 participants; ages 24-44

164 tudy ([NHS] aged 53-81 years, 2000-2008) and Nurses' Health Study II ([NHSII] aged 36-55 years, 2001-

165 ment 1976; follow-up 1982-2016; n = 81 869), Nurses' Health Study II (enrollment 1989; follow-up 2013

166 00) and 52,587 women aged 29-46 years in the Nurses' Health Study II (in 1993-2001).

167 h ASD and 17,728 comparison mothers from the Nurses' Health Study II (index births in 1991-2007).

168 dies-the Nurses' Health Study (n = 121,701), Nurses' Health Study II (n = 116,686), and Health Profes

169 ' Health Study I (n = 59,994 women), and the Nurses' Health Study II (n = 90,631 women).

170 -55 years; follow-up from 1992 to 2010), and Nurses' Health Study II (NHS II) (106,122 women aged 25-

171 ed case-control study of participants in the Nurses' Health Study II (NHS II), a prospective cohort o

172 cipants from the Nurses' Health Study (NHS), Nurses' Health Study II (NHS II), and the Health Profess

173 m the Nurses' Health Study (NHS; 1989-2010), Nurses' Health Study II (NHS II; 1996-2009), and the Wom

174 idence of early menopause in the prospective Nurses' Health Study II (NHS2).Intakes of vitamin D and

175 en in a case-control study nested within the Nurses' Health Study II (NHSII).

176 cholesterolemia among 69 505 US women in the Nurses' Health Study II (NHSII; 1991-2011).

177 idential location and ASD in the children of Nurses' Health Study II (United States) participants in

178 The Nurses' Health Study II ascertained lifetime trauma expo

179 among 40,773 eligible pregnancies in the US Nurses' Health Study II cohort (1989-2001).

180 In a case-control study nested within the Nurses' Health Study II cohort, we measured the concentr

181 n born in 1993-2005 to women enrolled in the Nurses' Health Study II cohort.

182 ce using data from the nationwide U.S.-based Nurses' Health Study II cohort.

183 men followed in the Nurses' Health Study and Nurses' Health Study II cohorts in 1980-2004.

184 2001, 35,794 mothers of participants of the Nurses' Health Study II completed a questionnaire inquir

185 DES exposure and incident UL in women in the Nurses' Health Study II from 1989 to 2009.

186 , the Nurses' Health Study I in 2000 and the Nurses' Health Study II in 1997.

187 -Hormone Trials (WHI-HT; n = 1,325), and the Nurses' Health Study II Mind-Body Study (NHSII-MBS; n =

188 with breast cancer among 45,204 women in the Nurses' Health Study II using reduced rank regression.

189 followed 93,835 US women aged 27-44 years in Nurses' Health Study II who had alcohol consumption data

190 risk factors from 13,864 participants in the Nurses' Health Study II who had completed a self-adminis

191 women ages 27 to 44 years at baseline in the Nurses' Health Study II who were followed from 1991 to 2

192 ts in the NHS (Nurses' Health Study), NHSII (Nurses' Health Study II), and Health Professionals Follo

193 , 1996-2008), a cohort of younger women (the Nurses' Health Study II, 1991-2005), and a cohort of men

194 ional analysis of 49,408 participants in the Nurses' Health Study II, a cohort comprising women nurse

195 Participants were drawn from the Nurses' Health Study II, a cohort of 116,430 female nurs

196 We used data from the Nurses' Health Study II, a longitudinal cohort study wit

197 Data were from the Nurses' Health Study II, a prospective cohort study.

198 The Nurses' Health Study II, a prospective observational stu

199 The Nurses' Health Study II, a US longitudinal cohort of wom

200 ses' Health Study (NHS), 93,054 women in the Nurses' Health Study II, and 40,557 men in the Health Pr

201 In an analysis of data from the Nurses' Health Study II, we did not observe a convincing

202 Among participants in the Nurses' Health Study II, who were younger than participa

203 -control study nested within the prospective Nurses' Health Study II.

204 d their mothers, who are participants in the Nurses' Health Study II.

205 s among 11,535 women who participated in the Nurses' Health Study II.

206 over a 20-year period in 49 978 women in the Nurses' Health Study II.

207 is in a case-control study nested within the Nurses' Health Study II.

208 luated this possibility in a substudy of the Nurses' Health Study II.

209 f exposure with risk of endometriosis in the Nurses' Health Study II.

210 nancy with this child as part of the ongoing Nurses' Health Study II.

211 life among 19,771 women participating in the Nurses' Health Study II.

212 irmed endometriosis among 70,556 US women in Nurses' Health Study II.

213 mong which 38 associations were validated in Nurses' Health Study II.

214 women aged 31-48 years at baseline (1995) in Nurses' Health Study II.

215 ohort study of 55,636 parous women in the US Nurses' Health Study II.

216 oods were associated with early menopause in Nurses' Health Study II.

217 weeks) and CVD in 70 182 parous women in the Nurses' Health Study II.

218 rvice attendance and religious coping in the Nurses' Health Study II.

219 molecule-1) in 524 middle-aged women in the Nurses' Health Study II.

220 ollowed 52,682 women aged 46-71 years in the Nurses' Health Study (in 1992-2000) and 52,587 women age

221 n a large, long-term prospective cohort, the Nurses' Health Study, in an analysis that included 89708

222 ctive cohort study among 41,844 women in the Nurses' Health Study, in the United States.

223 hort study was conducted using data from the Nurses' Health Study (June 1, 1980, to June 1, 2012) and

224 Based on data from the Nurses' Health Study, long-term intake of dietary fiber,

225 dults in 3 national, prospective studies-the Nurses' Health Study (n = 121,701), Nurses' Health Study

226 drawn from the two independent studies: the Nurses' Health Study (n = 1590) and the Health, Aging an

227 ipants from 2 large prospective cohorts: the Nurses' Health Study (n = 31,615) and the Health Profess

228 We used prospective data from the Nurses' Health Study (n = 70,021).

229 rofessionals Follow-up Study (HPFS), and the Nurses Health Study (NHS).

230 althy women followed up over 24 years in the Nurses' Health Studies (NHS [1988-2012]: N = 73,623 and

231 prospectively followed 74,578 women from the Nurses' Health Study (NHS) (1984-2016), 91,656 women fro

232 In the Nurses' Health Study (NHS) (enrolling during 1980-1994 a

233 971 incident T2D case-control pairs from the Nurses' Health Study (NHS) (mean age, 65.6 years) and NH

234 ividuals of European ancestry drawn from the Nurses' Health Study (NHS) (N = 1,591).

235 intake.We evaluated associations within the Nurses' Health Study (NHS) (n = 88,598) and the Health P

236 Participants were 49 407 women in the Nurses' Health Study (NHS) and 25 907 men in the Health

237 We followed 60,768 women from the Nurses' Health Study (NHS) and 40,744 men from the Healt

238 We followed 78,977 women from the Nurses' Health Study (NHS) and 41,202 men from the Healt

239 followed 59,930 women aged 37-65 y from the Nurses' Health Study (NHS) and 85,157 women aged 26-45 y

240 sectional data from 5013 participants in the Nurses' Health Study (NHS) and Health Professionals Foll

241 ers) and obesity risk in 6934 women from the Nurses' Health Study (NHS) and in 4423 men from the Heal

242 Data are from 2 cohorts, women from the Nurses' Health Study (NHS) and men from the Veterans Aff

243 /=10 (distant) years before diagnosis in the Nurses' Health Study (NHS) and NHSII with breast cancer

244 (HPFS) during 2000-2006 (33,901 men) and the Nurses' Health Study (NHS) during 1982-2006 (93,767 wome

245 sk of incident stroke in 86,149 women in the Nurses' Health Study (NHS) I and 94,715 women in the NHS

246 ata from 35,133 mother-daughter dyads of the Nurses' Health Study (NHS) II and the Nurses' Mothers' C

247 93 600 women 25 to 42 years of age from the Nurses' Health Study (NHS) II who were healthy at baseli

248 Beginning in 1980, Nurses' Health Study (NHS) participants completed dietar

249 specific mortality among 74,890 women in the Nurses' Health Study (NHS), 93,054 women in the Nurses'

250 ge baseline age was 63) participating in the Nurses' Health Study (NHS), an ongoing cohort study init

251 Women's Health across the Nation (SWAN), the Nurses' Health Study (NHS), and the Rancho Bernardo Stud

252 an existing case-control study nested in the Nurses' Health Study (NHS), including 1,303 incident dia

253 s in the United States were used, namely the Nurses' Health Study (NHS), NHS2, and the Health Profess

254 ctivity among 5,197 US participants from the Nurses' Health Study (NHS), Nurses' Health Study II (NHS

255 controls within the all-female cohort of the Nurses' Health Study (NHS).

256 rofessionals Follow-up Study (HPFS), and the Nurses' Health Study (NHS).

257 onwide prospective cohort of U.S. women: the Nurses' Health Study (NHS).

258 included from an older cohort of women (the Nurses' Health Study (NHS); 1996-2008), a younger cohort

259 prospectively observed 74,749 women from the Nurses' Health Study (NHS, 1984-2008) and 39,059 men fro

260 mic profiles, mostly lipid related, from the Nurses' Health Study (NHS, n = 1460) and Health Professi

261 st cancer identified during follow-up of the Nurses' Health Study (NHS; 1980-2010) and NHSII (1991-20

262 We followed 82,750 women from the Nurses' Health Study (NHS; 1980-2012), 89,636 women from

263 We followed 88,739 women from the Nurses' Health Study (NHS; 1980-2016) and 93,915 women f

264 Study (HPFS; 1986-2012), 65,929 women in the Nurses' Health Study (NHS; 1984-2012), and 89,565 women

265 in prospectively collected samples from the Nurses' Health Study (NHS; 1989-2010), Nurses' Health St

266 identified and confirmed among women in the Nurses' Health Study (NHS; 1990-2006) and among men in t

267 breast cancer of European ancestry from the Nurses' Health Study (NHS; P = 0.006); the association w

268 le-aged and older women for 8 years from the Nurses' Health Study ([NHS] aged 53-81 years, 2000-2008)

269 e collected in 3168 participants in the NHS (Nurses' Health Study), NHSII (Nurses' Health Study II),

270 al women with intact ovaries/uterus from the Nurses' Health studies (Nurses' Health Study (1989-1990)

271 the Health Professionals Follow-up Study and Nurses' Health Study, of whom 732 developed CVD.

272 Nurses' Health Study participants responded to a questio

273 Participants were 617 Nurses' Health Study participants with K-shell X-ray flu

274 stionnaire was administered every 4 years to Nurses' Health Study participants.

275 s to evaluate this issue prospectively among Nurses' Health Study participants.

276 Using data from the U.S.-based Nurses' Health Study prospective cohort, we defined cumu

277 A dataset from the Nurses' Health Study served as a replication cohort.

278 n (mean age, 65 +/- 7 years) enrolled in the Nurses' Health Study since 2000 and 28,989 men (mean age

279 cted a case-control sample nested within the Nurses' Health Study (starting year 1976, mean age = 51

280 cted a case-control sample nested within the Nurses' Health Study (starting year 1976, mean age=51 ye

281 risk of CHD in women who participated in the Nurses' Health Study, taking into account the duration o

282 analyzes cancer and lifestyle data from the Nurses' Health Study, the Health Professionals Follow-up

283 his study, we used data from the prospective Nurses' Health Study to evaluate whether the association

284 the Health Professionals Follow-up Study and Nurses' Health Study using multivariable-adjusted Cox pr

285 m 1980-2010 for 90,286 women enrolled in the Nurses' Health Study, we performed competing-risks regre

286 252 cases and 252 matched controls from the Nurses' Health Studies were included.

287 ancer samples from 1,841 participants in the Nurses' Health Study were scored for levels of nuclear H

288 (mean age, 73 years) who participated in the Nurses' Health Study, were enrolled since 2008, and with

289 to June 1, 2008) of 77 728 US women from the Nurses' Health Study who provided biennially updated dat

290 asthma in 76,470 asthma-free women from the Nurses' Health Study who were followed between 1988 and

291 pression risk among 32,900 US women from the Nurses' Health Study who were free from depressive sympt

292 analysis involving 49,821 US women from the Nurses' Health Study who were free from depressive sympt

293 n 2002 in a cohort of 46,289 US women in the Nurses' Health Study who were free of T2D, cardiovascula

294 We included 13,818 women from the Nurses' Health Study with dietary data and no major chro

295 conducted a nested case-control study in the Nurses' Health Study, with 1,506 invasive breast cancer

296 edian age, 54 years) enrolled in 1976 in the Nurses' Health Study without a prior history of CD or UC

297 ded 52,135 women (mean age: 44.2 y) from the Nurses' Health Study without chronic diseases in 1980 an

298 SCD among 101 018 women participating in the Nurses' Health Study without known coronary heart diseas

299 We included a subset of 78,980 Nurses' Health Study women and 41,221 Health Professiona

300 ples were collected from 1989 to 1990 in the nurses' health study (women) and from 1993 to 1995 in th

301 In the Nurses' Health Study, women with 30 years or more of shi